CPT code 87808 represents a laboratory technical immunoassay performed with direct optical (visual) observation to detect Trichomonas vaginalis. As a specific pathogen-detection test, this code matters nationally for infectious disease surveillance, outpatient and inpatient laboratory workflows, and billing consistency across clinical laboratories. Accurate coding of this test affects claims processing and reporting for sexually transmitted infection diagnostics.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage and payment policies for laboratory tests such as this often vary by payer, making standardized code use important for reimbursement and clinical reporting.

Readers will find an overview of the code’s clinical context and service setting, a summary of which major payers are included in the analysis, and guidance on what to expect from the publication: benchmarks for utilization and reimbursement (where available), relevant policy updates affecting laboratory testing, and practical considerations for coding and billing workflows. The report addresses national implications for laboratories and payers, and highlights areas where data is not available in the input.